Atlas Trials

TRimetazidine for acUte on Chronic Liver Failure STudy

Clinical trial NCT03737448 · SUSPENDED

Trial details

NCT number
NCT03737448
Sponsor
Martin Pharmaceuticals
Status
SUSPENDED
Phase
Phase 1
Study type
INTERVENTIONAL
Acute-On-Chronic Liver Failure
Start date
2018-11-28
Primary completion
2021-06-30
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.